Candriam Equities L Biotech.R EUR Acc H/ LU1708110975 /
| NAV9/21/2023 | Chg.-1.8600 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 182.1800EUR | -1.01% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017 | - | - | - | - | - | - | - | - | - | - | - | 1.34 | - |
| 2018 | 6.48 | -4.79 | -2.32 | -3.39 | 4.34 | 0.61 | 4.25 | 3.89 | -2.24 | -14.23 | 3.82 | -8.57 | -13.41% |
| 2019 | 12.85 | 3.39 | -0.87 | -5.17 | -4.67 | 9.21 | -2.39 | -2.50 | -4.71 | 10.98 | 11.86 | 2.55 | +31.84% |
| 2020 | -5.41 | -1.57 | -5.43 | 12.20 | 9.47 | 1.26 | -2.99 | 0.80 | 0.62 | -2.71 | 9.37 | 2.90 | +17.99% |
| 2021 | 1.79 | -2.59 | -4.38 | 2.68 | -2.29 | 6.32 | -1.48 | 3.86 | -4.28 | 0.14 | -4.42 | 2.30 | -3.01% |
| 2022 | -10.65 | -1.63 | 5.82 | -7.30 | -4.10 | 3.11 | 4.59 | 1.32 | -2.32 | 6.20 | 5.94 | -3.20 | -3.90% |
| 2023 | 2.74 | -5.80 | 0.12 | 2.17 | -1.09 | 1.27 | -0.67 | -0.36 | -3.46 | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 14.41% | 13.22% | 17.56% | 20.94% | 23.51% |
| Sharpe ratio | -0.78 | -0.27 | -0.04 | -0.22 | -0.06 |
| Best month | +2.74% | +2.17% | +6.20% | +9.37% | +12.85% |
| Worst month | -5.80% | -3.46% | -5.80% | -10.65% | -14.23% |
| Maximum loss | -10.39% | -8.16% | -12.25% | -31.39% | -31.39% |
| Outperformance | +0.89% | - | +2.14% | -5.05% | - |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.V US... | reinvestment | 1,802.2700 | +6.55% | +3.49% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 196.4300 | -2.35% | - | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,830.4399 | +3.17% | -3.47% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 1,973.0100 | -1.35% | +13.63% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,079.5701 | -1.86% | +6.29% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 322.4400 | -1.94% | +9.07% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 288.0200 | -1.47% | +15.37% | |
| Candriam Equities L Biotech.R CH... | reinvestment | 181.0200 | +1.47% | -3.93% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,607.4301 | +6.59% | +5.52% | |
| Candriam Equities L Biotech.I US... | reinvestment | 4,983.7998 | +4.99% | +4.19% | |
| Candriam Equities L Biotech.V US... | reinvestment | 527.8700 | +5.02% | +0.90% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 175.6800 | +2.96% | -4.17% | |
| Candriam Equities L Biotech.R US... | reinvestment | 235.7200 | +4.98% | +5.78% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 182.1800 | +3.28% | -1.85% | |
| Candriam Equities L Biotech.C US... | reinvestment | 739.1700 | +5.42% | +2.25% | |
| Candriam Equities L Biotech.C US... | paying dividend | 679.1400 | +5.39% | +2.15% |
Performance
| YTD | -5.24% | ||
|---|---|---|---|
| 6 Months | +0.15% | ||
| 1 Year | +3.28% | ||
| 3 Years | -1.85% | ||
| 5 Years | +13.29% | ||
| 10 Years | - | ||
| Since start | +22.22% | ||
| Year | |||
| 2022 | -3.90% | ||
| 2021 | -3.01% | ||
| 2020 | +17.99% | ||
| 2019 | +31.84% | ||
| 2018 | -13.41% | ||